Cardiovascular health is closely tied to long-term longevity outcomes. Several nutrients have been studied for their role in supporting heart function, managing key cardiovascular biomarkers, and contributing to normal physiological processes. Nutrients including omega-3 fatty acids, B vitamins, CoQ10, and magnesium have the most robust human evidence, with thiamine holding an EFSA-approved claim for contributing to normal heart function.
Key Takeaways
- Cardiovascular disease remains the leading cause of mortality globally, making heart-supportive nutrition an important aspect of any longevity-focused approach.1
- Omega-3 fatty acids (EPA and DHA) have been studied extensively for their role in triglyceride management and inflammatory pathways relevant to cardiovascular health.2
- Thiamine (vitamin B1) contributes to normal heart function; this is an EFSA-approved health claim for supplements that contain an adequate daily dose.
- Vitamin B6, B12, and Folate contribute to normal homocysteine metabolism; elevated homocysteine is an established cardiovascular risk marker studied in human cohort data.3
- CoQ10 has been studied for its role in cardiac energy production and has been investigated in human trials for individuals with compromised heart function.4
- Magnesium has been associated with blood pressure regulation and cardiac rhythm in human observational and intervention studies.5
- No supplement replaces cardiovascular medication, lifestyle intervention, or clinical care. Nutritional support is a complement to, not a substitute for, evidence-based cardiovascular management.
Why Cardiovascular Health Is Central to Longevity
Cardiovascular disease (CVD) is the leading cause of death worldwide and one of the primary drivers of reduced healthspan. The heart and vascular system underpin the function of every organ; when cardiovascular efficiency declines, systemic effects follow. For this reason, cardiovascular health occupies a central position in longevity research and in the formulation of evidence-based nutritional strategies.1
Several modifiable factors influence cardiovascular risk over a lifetime: diet quality, physical activity, body composition, blood pressure, lipid profiles, inflammatory load, and nutritional status. While medications are the primary intervention for diagnosed cardiovascular conditions, nutritional optimisation represents a meaningful supporting layer for those seeking to maintain cardiovascular function as they age. This article focuses on nutrients with human evidence and, where available, EFSA-approved claims.
It is important to state clearly from the outset: no supplement treats, prevents, or reverses cardiovascular disease. The role of nutritional supplementation in cardiovascular health is one of supporting normal physiological function, not replacing medical care. Individuals with existing cardiovascular conditions or those taking cardiac medications must consult a qualified healthcare professional before starting any supplement.
Omega-3 Fatty Acids and Cardiovascular Markers
Omega-3 long-chain polyunsaturated fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are among the most studied nutrients in cardiovascular research. Found predominantly in fatty fish and concentrated fish oil supplements, they have been the subject of large clinical trials and systematic reviews examining their effects on cardiovascular biomarkers and outcomes.1
Triglycerides: EPA and DHA have been consistently shown in human trials to reduce blood triglyceride concentrations. The effect is dose-dependent, with higher doses producing greater reductions. Prescription-strength omega-3 formulations (4 g per day EPA/DHA) are used clinically for hypertriglyceridaemia in multiple countries. Evidence from both dietary and supplement-based studies supports a role for omega-3 fatty acids in contributing to normal triglyceride metabolism.1
REDUCE-IT and high-dose EPA: The REDUCE-IT trial, a large randomised controlled trial involving 8,179 statin-treated patients with elevated triglycerides, found that 4 g per day of icosapentaenoic acid (a purified EPA formulation) was associated with a significant reduction in major cardiovascular events compared to placebo over a median 4.9 years of follow-up.2 This was a specific trial in a defined high-risk population; findings cannot be directly extrapolated to all individuals or to standard-dose omega-3 supplements.
Inflammation: EPA and DHA modulate the production of eicosanoids and other lipid mediators involved in inflammatory signalling. Human studies have linked higher omega-3 status to lower levels of C-reactive protein (CRP) and other inflammatory markers. This is consistent with a broader role in modulating chronic low-grade inflammation, which is a recognised feature of cardiovascular ageing. For more detail on the science of inflammation, see our Chronic Inflammation Hallmark Blog.
Endothelial function: Several short-term human intervention trials have reported improvements in endothelial function following omega-3 supplementation, measured via flow-mediated dilation. However, these studies are typically short-duration and use varied dosing protocols, making generalisation difficult. The American Heart Association acknowledges omega-3 consumption from fish or supplements as part of a heart-healthy dietary pattern.1
For an in-depth discussion of omega-3 fatty acid research, see Article 3: Omega-3 Fatty Acids and Longevity.
B Vitamins and Homocysteine Metabolism
Homocysteine is an amino acid produced during the metabolism of methionine. Elevated plasma homocysteine, a condition known as hyperhomocysteinaemia, has been associated with increased cardiovascular risk in numerous human observational studies and meta-analyses. The mechanism involves endothelial damage, increased oxidative stress, and prothrombotic effects.6
Three B vitamins are directly involved in homocysteine metabolism and carry EFSA-approved health claims for this function:
Vitamin B6, B12, and Folate contribute to normal homocysteine metabolism. These vitamins act as cofactors in the enzymatic pathways that convert homocysteine either back to methionine (via methylation, requiring B12 and folate) or forward to cysteine (via transsulphuration, requiring B6). Inadequate intake of any of these three vitamins can lead to elevated homocysteine levels.
Human intervention trials have demonstrated that supplementation with folic acid, B12, and B6 consistently reduces circulating homocysteine concentrations. A Cochrane systematic review of 15 randomised controlled trials examined homocysteine-lowering interventions and their effects on cardiovascular events. While homocysteine reduction was reliably achieved, the translation into reduced cardiovascular event rates was not consistently observed across trials, suggesting that homocysteine may be a marker of, rather than a sole driver of, cardiovascular risk.3 This nuance is important: lowering homocysteine with B vitamins is a biochemically supported and EFSA-approved function, but it should not be presented as preventing cardiovascular events.
Thiamine (Vitamin B1) contributes to normal heart function. This is an EFSA-approved health claim. Thiamine is a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, enzymes central to aerobic energy metabolism in cardiac muscle. The heart has a high metabolic demand and relies continuously on efficient ATP production. Thiamine deficiency (found in populations with restricted dietary access or chronic alcohol dependence) is associated with impaired cardiac function, which can be reversed with thiamine repletion. While most people in developed countries are not deficient, the physiological role of thiamine in cardiac energy metabolism is well established.
Betaine also contributes to normal homocysteine metabolism and may work synergistically with B vitamins in this pathway.
CoQ10 and Cardiac Energy Production
Coenzyme Q10 (CoQ10) is a lipid-soluble compound synthesised in the body that plays a central role in mitochondrial electron transport, the process by which cells generate ATP. The heart is one of the most metabolically demanding organs in the body, maintaining continuous output across a lifetime. CoQ10 concentrations in cardiac tissue are among the highest in the body, and human studies have noted reduced cardiac CoQ10 levels in individuals with compromised heart function.4
The Q-SYMBIO trial, a multicentre randomised controlled trial conducted across 17 centres in nine countries, enrolled 420 patients with chronic heart failure. Participants received either 300 mg CoQ10 per day or placebo for two years. The CoQ10 group showed significantly fewer major adverse cardiovascular events and lower cardiovascular mortality at two years compared to placebo. Importantly, this study was conducted in a defined patient population with established heart failure and should not be interpreted as evidence that CoQ10 prevents heart disease in healthy individuals.4
For generally healthy adults, CoQ10 supplementation has been studied for exercise performance, fatigue reduction, and endothelial function, with mixed results across trials. Levels of CoQ10 naturally decline with age and may be reduced by statin medications, though the clinical significance of statin-related CoQ10 depletion in most people remains debated. Individuals taking statins should discuss CoQ10 supplementation with their healthcare provider.
For detailed CoQ10 research, see Article 2: CoQ10 and Mitochondrial Health.
Magnesium and Cardiovascular Function
Magnesium is an essential mineral involved in over 300 enzymatic reactions, including those governing cardiac muscle contraction and relaxation, vascular tone, and electrolyte balance. Adequate magnesium status is considered important for maintaining normal blood pressure and cardiac rhythm. EFSA-approved claims for magnesium include contributions to normal muscle function and to the maintenance of normal bones, though no specific cardiovascular EFSA claim exists for magnesium alone.
A meta-analysis of 22 randomised controlled trials (1,173 participants) examined the effect of magnesium supplementation on blood pressure. The analysis found that magnesium supplementation was associated with a statistically significant reduction in systolic and diastolic blood pressure, with effects being more pronounced in participants with higher baseline blood pressure.5 Average effect sizes were modest, and the authors noted heterogeneity between trials in terms of dose, population, and study duration.
A subsequent systematic review and meta-analysis published in Nutrients examined dietary magnesium intake and cardiovascular disease risk across 40 prospective cohort studies. Higher magnesium intake was associated with lower risk of cardiovascular events and cardiovascular mortality, with a dose-response relationship observed.7 These findings are observational and do not establish causality, but they are consistent with the known physiological roles of magnesium in cardiovascular function.
Magnesium deficiency is more common than often recognised, particularly in populations with low vegetable and whole grain intake, or with conditions that impair absorption. For a detailed overview of magnesium research and supplementation, see Article 4: Magnesium and Longevity.
Polyphenols, Antioxidants, and Cardiovascular Context
Beyond the nutrients discussed above, a range of plant-derived compounds has been studied for cardiovascular relevance. These include flavonoids (found in berries, tea, and cocoa), resveratrol (found in grapes and red wine), and hydroxytyrosol (found in olive oil). Human evidence for specific isolated polyphenol supplements is generally less robust than for dietary patterns rich in these compounds.
The Mediterranean dietary pattern, which is rich in olive oil, vegetables, legumes, fish, and moderate wine consumption, is one of the most studied dietary approaches in cardiovascular research. Large prospective studies and the PREDIMED trial (a randomised controlled trial in Spain) have associated Mediterranean-style eating with reduced cardiovascular event rates in high-risk populations. However, this evidence pertains to dietary patterns, not individual supplement ingredients. The contribution of any single polyphenol in isolation remains an area of active research.
Vitamin C and Selenium both contribute to protection of cells from oxidative stress (EFSA-approved claims). Oxidative stress is implicated in endothelial dysfunction and the progression of atherosclerosis. These roles provide a mechanistic rationale for including antioxidant-active nutrients in a cardiovascular support strategy, though direct evidence for supplement-based antioxidants reducing cardiovascular events in healthy populations is mixed.
How to Evaluate Cardiovascular Supplement Quality
The quality and transparency of cardiovascular nutrient supplements varies considerably across the market. Several principles help identify products that meet the highest standards.
Third-party testing: Independent laboratory verification is the most reliable way to confirm that a supplement contains what its label states, in the declared amount, and is free from contaminants. A Certificate of Analysis (COA) from an accredited laboratory, such as Eurofins, provides this assurance. NZVT doping-free certification is an additional marker relevant for those in regulated sport.
Ingredient form and bioavailability: Different forms of the same nutrient can vary in bioavailability. For omega-3 supplements, the triglyceride form is generally considered to have superior bioavailability to the ethyl ester form. For CoQ10, ubiquinol (the reduced form) has been shown in some pharmacokinetic studies to have higher absorption, particularly in older adults with potentially lower conversion capacity.
Dosage transparency: Products should clearly state the quantity of each active ingredient per serving. Proprietary blends that obscure individual dosages make it impossible to compare against studied doses. Meaningful dosages of nutrients should align with amounts used in the human trials referenced above.
Formulation integrity: Cardiovascular supplements often contain multiple ingredients. It is important to confirm that all included ingredients have a science-based rationale, that no claims exceed regulatory approval, and that combination products do not create interaction risks.
Longevity Complete includes thiamine (which contributes to normal heart function), vitamin B6, B12, and folate (which contribute to normal homocysteine metabolism), magnesium (which contributes to normal muscle function), and several antioxidant-active nutrients. All claims used in connection with this product align with EFSA-approved wording. Third-party testing and COA availability are central to the product's quality assurance philosophy.
Q&A: Cardiovascular Nutrients and Longevity
What nutrients are most studied for heart health in humans?
The nutrients with the most robust human evidence for cardiovascular relevance include omega-3 fatty acids (EPA and DHA), B vitamins (particularly folate, B6, and B12 for homocysteine metabolism), CoQ10 (studied in cardiac energy production contexts), and magnesium (associated with blood pressure and cardiac rhythm).1,5 Thiamine carries an EFSA-approved claim for contributing to normal heart function. Evidence quality and effect sizes vary considerably between nutrients and populations studied.
Does thiamine support heart health?
Thiamine (vitamin B1) contributes to normal heart function; this is an EFSA-approved health claim applicable when a supplement contains an adequate daily dose of thiamine. Thiamine is an essential cofactor for enzymes involved in aerobic energy metabolism in cardiac muscle. While outright thiamine deficiency is uncommon in most populations today, maintaining adequate thiamine intake is important for normal cardiovascular physiology.
What is homocysteine and why does it matter for the heart?
Homocysteine is an amino acid produced during normal protein metabolism. When plasma homocysteine concentrations are elevated, it is associated with an increased risk of cardiovascular events in human epidemiological studies.6 Vitamins B6, B12, and folate are essential cofactors in the metabolic pathways that clear homocysteine from circulation. EFSA has approved the claim that these vitamins contribute to normal homocysteine metabolism.
Can omega-3 supplements benefit the heart?
Human research suggests that omega-3 fatty acids (EPA and DHA) have a meaningful effect on blood triglyceride levels and play a role in inflammatory pathways relevant to cardiovascular health.1 The evidence is strongest for triglyceride management, particularly at higher doses. The American Heart Association advises omega-3 consumption as part of a heart-healthy dietary pattern. Omega-3 supplements do not treat or prevent cardiovascular disease.
Is CoQ10 useful for cardiovascular health?
CoQ10 has been studied in human trials for its role in cardiac energy production. The Q-SYMBIO trial showed meaningful outcomes in a specific population of patients with established chronic heart failure using 300 mg per day over two years.4 Evidence in generally healthy adults is less robust. CoQ10 cannot be claimed to treat or prevent cardiovascular disease; it is studied for its role in cellular energy metabolism in cardiac tissues.
Does magnesium affect blood pressure?
A meta-analysis of 22 randomised controlled trials found that magnesium supplementation was associated with modest but statistically significant reductions in both systolic and diastolic blood pressure.5 Effects were more pronounced in individuals with elevated baseline blood pressure. Magnesium contributes to normal muscle function (EFSA-approved) and is physiologically important for vascular tone and cardiac rhythm, though it has no specific EFSA cardiovascular claim.
Can supplements replace heart medication?
No. Supplements are not intended to replace cardiovascular medications. Individuals with diagnosed cardiovascular conditions, high blood pressure, high cholesterol, or who are taking cardiac medications must continue to work with their healthcare provider. Nutritional support plays a complementary, not a substitutive, role in cardiovascular health.
What is the best longevity stack for heart health?
No single "best" stack exists, as individual cardiovascular needs vary based on diet, health status, and specific risk factors. Human evidence supports attention to omega-3 status, B vitamin adequacy (particularly for homocysteine management), adequate magnesium intake, and CoQ10 as ingredients worthy of consideration.1,3,5 Third-party tested products with transparent dosing and documented ingredient quality are the foundation of a credible cardiovascular-support stack.
FAQ
What is the best longevity drink for heart health?
No single drink has been proven to support cardiovascular health in isolation. Human research indicates that diets rich in omega-3 fatty acids, polyphenols, and key micronutrients like magnesium and B vitamins are associated with better cardiovascular outcomes.1 A well-formulated longevity supplement drink that includes thiamine (which contributes to normal heart function), B vitamins, and magnesium within an evidence-based, third-party tested formula may complement a heart-healthy dietary pattern.
What is the best longevity stack for heart health?
A science-informed cardiovascular longevity stack should include nutrients with documented human evidence: omega-3 fatty acids (EPA/DHA), B vitamins including thiamine, B6, B12, and folate for homocysteine metabolism, magnesium, and CoQ10 where relevant.3,5 Quality markers including third-party testing and a Certificate of Analysis are essential considerations when selecting any supplement for cardiovascular support.
What are the top longevity science supplements for heart health?
The supplements with the strongest human evidence in a cardiovascular context include omega-3 fatty acids (EPA and DHA), CoQ10 studied for cardiac energy, B vitamins for homocysteine metabolism, and magnesium for vascular function and blood pressure.4,5 Thiamine is the only ingredient in this group with a direct EFSA-approved claim specifically for contributing to normal heart function. No supplement prevents or treats cardiovascular disease.
What is the top longevity support for heart health?
Evidence-based cardiovascular longevity support combines a heart-healthy dietary pattern, regular physical activity, and targeted nutritional supplementation where dietary gaps exist. Within the supplement space, the strongest support comes from nutrients that carry either EFSA-approved health claims (thiamine, B6, B12, folate) or have consistent human trial data (omega-3 fatty acids, CoQ10, magnesium).1,3 Always consult a healthcare professional if you have a cardiovascular condition.
Do B vitamins support heart health?
Vitamin B6, B12, and folate contribute to normal homocysteine metabolism (EFSA-approved claim). Elevated homocysteine is an established cardiovascular risk marker in human epidemiological research.6 Maintaining adequate B vitamin status to support normal homocysteine metabolism is a well-documented nutritional approach within cardiovascular health, though B vitamin supplementation should not be presented as preventing cardiovascular disease. Thiamine additionally contributes to normal heart function (EFSA-approved).
Is CoQ10 a good supplement for the heart?
CoQ10 is a naturally synthesised compound central to mitochondrial energy production. Human trial data, particularly the Q-SYMBIO randomised controlled trial, has studied CoQ10 (300 mg/day) in individuals with chronic heart failure and reported favourable outcomes in that specific population.4 For generally healthy individuals, evidence is more limited. CoQ10 does not treat heart disease and should not replace cardiac medications. For a full review of CoQ10 evidence, see Article 2: CoQ10 and Mitochondrial Health.
References
- Rimm EB, Appel LJ, Chiuve SE, et al. Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2018;138(1):e35-e47. View on PubMed ↗
- Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22. View on PubMed ↗
- Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8(8):CD006612. View on PubMed ↗
- Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649. View on PubMed ↗
- Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66(4):411-418. View on PubMed ↗
- Clarke R, Lewington S, Sherliker P, Armitage J. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia. Curr Opin Clin Nutr Metab Care. 2007;10(1):32-39. View on PubMed ↗
- Rosique-Esteban N, Guasch-Ferre M, Hernandez-Alonso P, Salas-Salvado J. Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies. Nutrients. 2018;10(2):168. View on PubMed ↗
- Del Gobbo LC, Imamura F, Wu JHY, et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98(1):160-173. View on PubMed ↗
- Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol. 2004;44(1):152-158. View on PubMed ↗
- Estruch R, Ros E, Salas-Salvado J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. View on PubMed ↗
